Swirl sign in intracerebral haemorrhage: definition, prevalence, reliability and prognostic value by unknown
Selariu et al. BMC Neurology 2012, 12:109
http://www.biomedcentral.com/1471-2377/12/109RESEARCH ARTICLE Open AccessSwirl sign in intracerebral haemorrhage:
definition, prevalence, reliability and prognostic
value
Eufrozina Selariu1, Elisabet Zia2, Marco Brizzi2 and Kasim Abul-Kasim1*Abstract
Background: Swirl sign has previously been described in epidural hematomas as areas of low attenuation,
radiolucency or irregular density. The aims of this study were to describe swirl sign in ICH, study its prevalence,
study the reliability of the subjective evaluation on computed tomography (CT), and to explore its prognostic value.
Methods: CTs of 203 patients with ICH were retrospectively evaluated for the presence of swirl sign. Association
between swirl sign and different clinical and radiological variables was studied.
Results: Inter- and intraobserver agreement with regard to the occurrence of swirl sign was substantial (К 0.80) and
almost perfect (К 0.87), respectively. Swirl sign was found in 30% of the study population. 61% of patients with swirl
sign were dead at one month compared with 21% of those with no swirl sign (p < 0.001). Only 19% of patients
with swirl sign exhibited favorable outcome at three months compared with 53% of those with no swirl sign (p <
0.001). Patients with swirl sign exhibited larger ICHs with average ICH-volume 52 ± 50 ml (median 42 ml) compared
with 15 ± 25 ml (median 6) in patients whose CT did not show swirl sign (p < 0.001). Swirl sign was independent
predictor of death at one month (p = 0.03; adjusted odds ratio 2.6, 95% CI 1.1 – 6), and functional outcome at
three months (p = 0.045; adjusted odds ratio 2.6, 95% CI 1.02 – 6.5).
Conclusions: As swirl sign showed to be an ominous sign, we recommend identification of this sign in cases of
ICHs.
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One-month case fatality rate among patients with intra-
cerebral haemorrhage (ICH) is high, 25–50% [1,2].
Haemorrhage volume is an important prognostic factor
[3] and in one third of patients with ICH, there is an ex-
pansion of the hematoma volume during the first hours
after ictus [4]. Identification of patients with ICH with a
potential risk for hematoma expansion is crucial for
planning of the treatment and prediction of the func-
tional outcome. With the advent of computed tomog-
raphy angiography (CTA) in the last decade, spot sign or
contrast extravasation has been shown to be an inde-
pendent predictor of hematoma expansion [5]. However,* Correspondence: kasim.abul-kasim@med.lu.se
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reproduction in any medium, provided the orCTA requires iodine contrast administration that might
be harmful in older patients especially those with im-
pairment of renal function. Therefore, scrutinizing plain
CT for other possible signs that might have prognostic
value is worthwhile for patients with potential contrain-
dications to contrast administration.
On non-enhanced computed tomography (CT), swirl
sign was originally described as areas of low attenuation
or radiolucency inside intracranial hyperattenuated hema-
tomas [6,7]. Zimmerman et al. have studied swirl sign in
45 epidural hematomas and concluded that this sign indi-
cates active bleeding that warrant immediate surgical
treatment [8]. In another report, 13 patients with acute
subdural and epidural hematoma found to have fresh non-
clotted blood upon surgical exploration and in 11 of them
active bleeding foci were identified [9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Different examples of swirl sign and swirl sign mimics.
Axial images of 6 different patients with ICH. (a–c) Show different
forms of swirl sign; well defined in a, irregular in b, and streak-like in
c. (d) Shows homogeneously hyperattenuated left-sided putaminal
haemorrhage with no swirl sign. (e) Shows right-sided subacute
frontal haemorrhage with lower attenuation (black arrow) at the
outer posterior portion indicating beginning resorption (clot
retraction) that should not be addressed as swirl sign. (f) Shows
left-sided subacute frontal haemorrhage with multiple blood-fluid
levels (short arrows) that should not be addressed as swirl sign.
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depth. The aims of this study were to (a) describe swirl
sign and its different imaging varieties in ICH, (b) study
its prevalence among patients with ICH, (c) explore the
subjective inter- and intraobserver reliability in evaluating
this sign on non-enhanced CT, and finally (d) find out if
the occurrence of this sign has any prognostic value.
Methods
This study included patients with spontaneous ICH admit-
ted to our university hospital, between January 2007 and
June 2009. Our hospital is the only one serving the popu-
lation of about 300 000. Patients with ICD code I10.1-9
were identified from the National Hospital Discharge
Register [10]. A research nurse, neurologists and a neuror-
adiologist validated the diagnosis by reviewing the medical
records and CTs of these patients, respectively.
Information about diabetes (diet or pharmacological
treatment), treatment with antithrombotics (Aspirin,
Clopidogrel, Dipyridamole), warfarin treatment, hyper-
tension medication, smoking habit (current smoker/non
smoker) on admission, and the time between onset of
stroke and arrival to hospital, was retrieved from patient
medical journal. Level of consciousness on admission
was assessed according to the Reaction Level Scale (RLS
85 scale) [11,12]. The RLS scores were categorized into
three groups: RLS score = 1 (alert), score 2–3 (drowsy)
and score ≥ 4 (unconscious).
All patients included in this study were subjected to
non-enhanced head CT on admission. All examinations
were performed at 16 slice multidetector CT-scanner
(SOMATOM 16 Sensation, Siemens AG, Forchheim,
Germany). Axial 4.5 mm thick slices and reconstructed
3 mm coronal images were used for the evaluation in
the Picture Archiving and Communication System
(PACS, SECTRA). 0.75 mm thick slices were also avail-
able in PACS enabling further multiplanar reconstruc-
tion (MPR) when needed. The images were evaluated
with regard to: (a) Swirl sign, (b) side and site of the
ICH, (c) presence of midline shift, (d) intraventricular
haemorrhage, (e) presence of white matter changes
according to Wahlund score [13], and (f ) haemorrhage
volume. The maximum haemorrhage width (W, trans-
verse diameter), length (L, anteroposterior diameter) and
height (H, craniocaudal diameter) were measured and
the haemorrhage volume was estimated using the fol-
lowing formula (W x L x H x 0.5). Swirl sign was evalu-
ated independently by 2 neuroradiologists (KAK, ES)
experienced in stroke imaging. At the time of evaluation
of swirl sign, the readers were blinded to the clinical
data. One reader (KAK) has performed the same evalu-
ation at two different occasions with 8- weeks interval.
Swirl sign was defined as region(s) of hypoattenuation
or isoattenuation (compared to the attenuation of brainparenchyma) within the hyperattenuated ICH. The areas
of hypoattenuation or isoattenuation may vary in shape
and can be rounded, streak-like or irregular, Figure 1.
The sign should be observed on both axial and coronal
plane. In cases where readers disagreed about the pres-
ence of swirl sign, performing joint panel evaluation by
the two readers made the final decision about the occur-
rence of swirl sign.
Information about the date of death was assessed from
the National Cause of Death Register [14]. All patients
with validated stroke diagnosis at the hospital are rou-
tinely registered in a National Stroke Register [15].
Modified Rankin Scale (mRS) [16] at three months as a
measure of functional outcome was achieved from the
three months follow-up questionnaire in this register.
Eriksson et al. created a key to convert those self-
reported answers into mRS [17]. Upon analysis of the
functional outcome, patients with mRS of ≤ 3 were con-
sidered to have favorable outcome whereas patients with
mRS ≥ 4 were considered to have unfavorable outcome.
This project was approved by the Regional Ethical Re-
view Board- Lund, Sweden (LU 238–02).
Statistical analysis
All statistical analyses were performed by means of Stat-
istical Package for the Social Sciences (SPSS) version 18.
Data is presented as proportions (%) or as mean ±
standard deviations (SD). The degree of interobserver
and intraobserver agreement with regard to the
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tion and calculation of kappa (К-value). The interpret-
ation of kappa values was done according to the one
proposed by Landis [18]. A kappa of 1 indicates total
agreement whereas a kappa of zero means poor agree-
ment and indicates that any observed agreement is
attributed to chance. Mann Whitney-U test has been
used to test the association between categorical and con-
tinuous variables, and chi-square test for the association
between categorical variables. Logistic regression ana-
lysis was performed to find out if swirl sign was an inde-
pendent predictor of death at one month and functional
outcome at three months. Variables with p < 0.05 in uni-
variate analysis were considered as potential confoun-
ders and included in the final model.
Results
Characteristics of study cohort
This study included 203 patients with spontaneous ICH
with mean age of 73 ± 14 years (range 29–97); 112
(55%) were females. The mean age of patients whose ini-
tial CT showed swirl sign was the same as that of
patients with no swirl sign (73 years).
Inter- and intraobserver reliability
The interobserver agreement (i.e. the agreement between
the two readers that performed the evaluation of CTs
with regard to the occurrence of swirl sign) was substan-
tial (К- value of 0.80; 95% CI 0.71 – 0.89) whereas the
intraobserver agreement (i.e. the agreement between the
assessment done by the reader who performed the same
evaluation at two different occasions) was almost perfect
(К- value of 0.87; 95% CI 0.80 – 0.94).
In 14 out of 203 patients, the two readers were not
agreed about the status of swirl sign at any of the three
occasions of evaluation. Four out of these 14 patients
had small bleedings with a volume ≤ 5 ml. The final deci-
sion about the occurrence of swirl sign was made by
joint evaluation of the two readers to reach a consensus.
Prevalence of swirl sign in study population
Swirl sign was found on the non-enhanced CT of 61
(30%) out of 203 patients with ICH. In ICHs with haem-
orrhage volume 5–30 ml, the incidence of swirl sign was
41% (57 out of 138 patients) compared with 62% in
patients with haemorrhage volume ≥ 30 ml (33 out of
53 patients), p = 0.010. Of 65 with haemorrhage volume
1–4 ml, only 4 (6%) showed swirl sign.
Association of swirl sign with different clinical variables
There was no significant association between the occur-
rence of swirl sign and the gender, diabetes mellitus, his-
tory of former stroke, smoking or treatment with platelet
activator inhibitor or Warfarin. Of 128 patients withantihypertensive treatment at admission, CTs of only 30
patients (23%) showed swirl sign compared to 31 out of 74
(42%) patients with no antihypertensive treatment
(p= 0.005), Table 1. Regarding the level of consciousness
upon arrival to hospital, 19 out of 35 patients (54%) with
RLS≥ 4 showed swirl sign on the initial CT compared with
19 out of 99 patients (19%) with RLS 1 (p< 0.001), Table 1.
Of 88 patients who arrived to the emergency department
within 2 h from symptom onset, 32 (36%) showed swirl
sign compared with 4 out of 31 (13%) patients who arrived
after 24 h (p= 0.051), Table 1.
Association of swirl sign with different radiological
variables
Out of 203 patients, 102 had ICH on the left side. 91
patients (45%) had deep haemorrhage and 82 (40%) had
lobar haemorrhage, Table 1. None of the above variables
was significantly associated with the occurrence of swirl
sign, Table 1. The average haemorrhage volume among
patients whose initial CT showed swirl sign was
52 ± 50 ml (median 42 ml) compared with 15 ± 25 ml
(median 6) in patients whose CT did not show swirl sign
(p < 0.001). 30 out of 61 (49%) patients with swirl sign
exhibited midline shift, whereas among 142 patients with
no swirl sign, only 23 (16%) exhibited midline shift
(p < 0.001). Intraventricular haemorrhage occurred
among 33 out of 61 patients (54%) with swirl sign com-
pared with 35 (25%) among 142 patients whose initial
CT did not show swirl sign (p < 0.001) Table 1.
Death and functional outcome
Out of 61 patients with swirl sign, 37 (61%) were dead at
one month compared with 29 out of 141 (21%) whose
CT did not show swirl sign (P < 0.001), Table 2. Data on
mRS were available on 188 out of 203 patients, 59 (31%)
showed swirl sign on initial CT. Only 11 of 59 (19%)
patients with swirl sign exhibited favorable outcome at
three months (mRS ≤ 3). Among patients whose initial
CT did not show swirl sign, 53% (69 out of 129) showed
favorable outcome at three months (P < 0.001), Table 2.
After adjustment for potential confounders, logistic re-
gression analysis showed that swirl sign was an inde-
pendent predictor of death at one month (p = 0.03;
adjusted odds ratio 2.6, 95% CI 1.1 – 6), and functional
outcome at three months (p = 0.045; adjusted odds ratio
2.6, 95% CI 1.02 – 6.5).
Discussion
This study showed that the subjective evaluation of swirl
sign on non-enhanced CT is a reliable method. Swirl
sign was found in 30% of our study population of 203
patients with ICH. Already in 1976, New et al. studied
the CT attenuation of different blood components and
concluded that extravasated blood may have attenuation
Table 1 The association between the occurrence of swirl sign and different variables included in the analysis of this
study
Swirl sign OR (95% CI) p-value
Negative Positive Total
Gender Male 64 (70) 27 (30) 91
Female 78 (70) 34 (30) 112 1 (0.5-2) 0.520
Diabetes mellitus Yes 17 (74) 6 (26) 23
No 125 (69) 55 (31) 180 1.3 (0.4-3.8) 0.431
Former stroke (1) Yes 30 (77) 9 (23) 39
No 111 (68) 52 (32) 163 1.6 (0.7-3.8) 0.189
Smoking (5) Yes 16 (70) 7 (30) 23
No 123 (70) 52 (30) 175 1 (0.4-2.8) 0.558
Hypertension treatment on admission (1) Yes 98 (77) 30 (23) 128
No 43 (58) 31 (42) 74 2.4 (1.2-4.6) 0.005
Acetyl salicylic acid treatment (11) Yes 22 (59) 15 (41) 37
No 112 (72) 43 (28) 155 0.6 (0.3-1.3) 0.306
Warfarin treatment (9) Yes 12 (67) 6 (33) 18
No 123 (70) 53 (30) 176 0.9 (0.3-2.7) 0.483
Platelet activator inhibitor treatment (11) Yes 25 (61) 16 (39) 41
No 109 (72) 42 (28) 151 0.6 (0.3-1.3) 0.117
Time to hospital (6) < 2 h 56 (64) 32 (36) 88
2-24 h 54 (69) 24 (31) 78
> 24 h 27 (87) 4 (13) 31 0.3 (0.1-0.9) 0.051
RLS (5) 1 80 (81) 19 (19) 99
2 – 3 41 (64) 23 (36) 64
≥ 4 16 (46) 19 (54) 35 5 (2–12,6) <0.001
Side Left 68 (67) 34 (33) 102
Right 74 (73) 27 (27) 101 0.7 (0.4-1.4) 0.192
Location Lobar 55 (67) 27 (33) 82
Deep 66 (73) 25 (27) 91
Brain stem 9 (82) 2 /18) 11
Cerebellum 11 (65) 6 (35) 17
Multiple 1(50) 1 (50) 2 0.8 (0.4-1.6) 0.745
Midline shift Yes 23 (43) 30 (57) 53
No 119 (79) 31 (21) 150 0.2 (0.1-0.4) <0.001
Intraventricular hemorrhage Yes 35 (51) 33 (49) 68
No 107 (79) 28 (21) 135 0.3 (0.1-0.6) <0.001
White matter lesions, Wahlund score 0 34 (65) 18 (35) 52
1 44 (75) 19 (25) 63
2 25 (71) 10 (29) 35
3 39 (74) 14 (26) 53 0.7 (0.3-1.7) 0.118
Figures between parentheses in the first column show the number of the missing data in each of the studied variables.
Figures between parentheses under swirl sign (column 3 and 4) show percentage.
p-values written in bold are statistically significant.
RLS reaction level scale, OR Odds ratio. 95%, CI 95% confidence interval.
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and an acute intraaxial haemorrhage might appear less
dense than the brain [19]. Swirl sign was reported
among 58% (26 out of 45) patients with of epiduralhematomas and upon surgical exploration of 25 patients,
23 patients (92%) showed evidence of active bleeding [8].
Barras et al. [20] studied the shape and the density of
ICHs and showed that large ICHs were significantly
Table 2 The association between the occurrence of swirl sign and death at one month and the functional outcome
according to mRS
Swirl sign OR (95% CI) p-value
Negative Positive
Death one month* Yes 29 (44) 37 (56)
No 112 (82) 24 (18) 0.2 (0.1-0.3) < 0.001
mRS** Favorable 69 (86) 11 (14)
Unfavorable 60 (56) 48 (44) 5 (2.3-11.3) < 0.001
Figures between parenthesis are percentage.
* The number of the missing data is 1 patient. ** The number of the missing data is 15 patients.
mRS Modified Rankin Scale, favorable outcome: mRS≤ 3, unfavorable outcome: mRS≥ 4.
OR Odds ratio. 95%, CI 95% confidence interval.
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had greater growth. They concluded that density hetero-
geneity independently predicted ICH growth. Density
heterogeneity in that study correspond what Zimmerman
et al. [8] and we in this study call “Swirl sign”. Kim et al.
[5] showed that swirl sign among other predictors was
associated with increased mortality but on multivariate
analysis only contrast extravasation on CT-angiography
(spotsign)independently predicted mortality and hematoma
growth.
To the best of our knowledge, there is no previous re-
port on the association between the occurrence of swirl
sign in ICH and the functional outcome. Our study
showed that swirl sign is an ominous sign as it was asso-
ciated with increased rate of death during the first
month, unfavorable functional outcome at three months
and was assocaited with serious radiological signs such
as midline shift and intraventricular haemorrhage.
Dowlatshahi et al. showed that smaller hematomas are
associated with less hematoma expansion and good out-
come [21]. In our study, ICHs with no swirl sign was
smaller than those with swirl sign, which might indir-
ectly indicate lower risk of hematoma expansion in the
absence of swirl sign.
Patients arriving to hospital later than 24 h after onset
of symptoms showed swirl sign less frequently than
patients arriving earlier than 2 h indicating that those
patients survived the phase of active bleeding and upon
arrival after 24 h their haemorrhages were often solid
and clotted. Identification of patients with ongoing
haemorrhage is of utmost importance in order to pro-
vide early and appropriate care and treatment. Apart
from care in acute stroke unit, surgery in selected cases
is so far the only recommended treatment. However,
several ongoing pharmacological trials have focus on
limiting hematoma growth in the acute phase [22].
Among the shortcomings of this study were its retro-
spective nature and the lack of the consecutive CT
follow-up that allow studying the hematoma expansion.
However, our study showed that ICHs with swirl sign
exhibited larger volume than those with no swirl sign.An important potentially confounding variable was the
lack of data about the time between arrival to hospital
and the CT scan as we in this study only reported the
time between the onset of stroke and arrival to hospital.
However, our hospital has well established emergency
routines for patients presenting with stroke. In a recent
report from our institution, the median value for the
time between arrival to hospital and CT-scan was
21 min (mean 27) [23].
As midline shift, intraventricular involvement and
large haemorrhage volume have in our study shown to
occur more frequently among patients with swirl sign
and as these signs has previously proved to be a poor
prognostic signs [4,24,25], radiologists should be learned
to search for and report this sign during the work-up of
ICH.
Conclusion
This study showed that swirl sign in ICHs was an inde-
pendent predictor of death at one month and unfavor-
able functional outcome at three months. Thus, swirl
sign is an ominous sign and we recommend identifica-
tion of this sign in cases of ICHs.
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